GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Soho Global Health Tbk (ISX:SOHO) » Definitions » Net Interest Income

PT Soho Global Health Tbk (ISX:SOHO) Net Interest Income : Rp11,438 Mil (TTM As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is PT Soho Global Health Tbk Net Interest Income?

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors. PT Soho Global Health Tbk's net interest income for the three months ended in Dec. 2024 was Rp2,962 Mil. Its net interest income for the trailing twelve months (TTM) ended in Dec. 2024 was Rp11,438 Mil.

PT Soho Global Health Tbk Net Interest Income Historical Data

The historical data trend for PT Soho Global Health Tbk's Net Interest Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PT Soho Global Health Tbk Net Interest Income Chart

PT Soho Global Health Tbk Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Net Interest Income
Get a 7-Day Free Trial -13,117.00 11,147.00 9,071.00 21,504.00 11,438.00

PT Soho Global Health Tbk Quarterly Data
Dec19 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Net Interest Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6,255.00 3,421.00 2,902.00 2,153.00 2,962.00

PT Soho Global Health Tbk Net Interest Income Calculation

Net interest income is the total interest income minus total interest expense. It represents the difference between interest and dividends earned on interestbearing assets and interest paid to depositors and other creditors.

Net Interest Income for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was Rp11,438 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PT Soho Global Health Tbk Net Interest Income Related Terms

Thank you for viewing the detailed overview of PT Soho Global Health Tbk's Net Interest Income provided by GuruFocus.com. Please click on the following links to see related term pages.

PT Soho Global Health Tbk Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » PT Soho Global Health Tbk (ISX:SOHO) » Definitions » Net Interest Income
Comparable Companies
ISX:EPMT ISX:KAEF ISX:IRRA ISX:SDPC ISX:ZBRA MCK COR CAH ASX:SIG SHSE:601607 HSIC HKSE:01099 SHSE:600332 MIL:AMP XSWX:GALE NZSE:EBO SHSE:600998 TSE:7459 SHSE:600511 PDCO
Traded in Other Exchanges
N/A
Address
Jalan Rawa Sumur II Kav BB No. 3, Kawasan Industri Pulogadung, Kel., Jatinegara, Kec. Cakung, Jakarta Timur, Jakarta, IDN, 13930
Website
https://www.sohoglobalhealth.com
PT Soho Global Health Tbk is a healthcare company operating in the areas of natural/herbal health care products and services. The company manufactures and distributes pharmaceutical products to herbal cures, proprietary medicines and health foods under various brand names such as Curcuma Plus; Curcuma Plus Milk; Imboost; Fitkom; Diapet; Laxing; Lelap; Asthma Soho; and Sohobion. Its segment includes Distribution; Professional product; Consumer health; Alliance and others. The company generates maximum revenue from the Distribution segment.